CA2346075A1 - Antimicrobial enzymes in animal feed - Google Patents
Antimicrobial enzymes in animal feed Download PDFInfo
- Publication number
- CA2346075A1 CA2346075A1 CA002346075A CA2346075A CA2346075A1 CA 2346075 A1 CA2346075 A1 CA 2346075A1 CA 002346075 A CA002346075 A CA 002346075A CA 2346075 A CA2346075 A CA 2346075A CA 2346075 A1 CA2346075 A1 CA 2346075A1
- Authority
- CA
- Canada
- Prior art keywords
- feed
- composition according
- enzymes
- animal
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 104
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 104
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 19
- 241001465754 Metazoa Species 0.000 title claims description 45
- 229940088598 enzyme Drugs 0.000 claims abstract description 103
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 49
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims abstract description 34
- 108010014251 Muramidase Proteins 0.000 claims abstract description 33
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 33
- 229960000274 lysozyme Drugs 0.000 claims abstract description 33
- 239000004325 lysozyme Substances 0.000 claims abstract description 33
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 32
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 32
- 238000006243 chemical reaction Methods 0.000 claims abstract description 27
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 25
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 25
- 241000894006 Bacteria Species 0.000 claims abstract description 14
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 11
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 11
- 210000002421 cell wall Anatomy 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 244000144977 poultry Species 0.000 claims abstract description 9
- 241000282849 Ruminantia Species 0.000 claims abstract description 8
- 230000001737 promoting effect Effects 0.000 claims abstract description 5
- 231100000331 toxic Toxicity 0.000 claims abstract description 4
- 230000002588 toxic effect Effects 0.000 claims abstract description 4
- 102000016943 Muramidase Human genes 0.000 claims abstract 5
- 239000000203 mixture Substances 0.000 claims description 50
- 108010015776 Glucose oxidase Proteins 0.000 claims description 27
- 239000004366 Glucose oxidase Substances 0.000 claims description 24
- 229940116332 glucose oxidase Drugs 0.000 claims description 24
- 235000019420 glucose oxidase Nutrition 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 14
- 241000287828 Gallus gallus Species 0.000 claims description 12
- 244000005700 microbiome Species 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 9
- 230000009261 transgenic effect Effects 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 7
- 239000003674 animal food additive Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 230000000813 microbial effect Effects 0.000 claims description 4
- 241000907999 Mortierella alpina Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 235000019730 animal feed additive Nutrition 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- -1 fatty acid ester Chemical class 0.000 claims description 3
- 235000021588 free fatty acids Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 241000228212 Aspergillus Species 0.000 claims description 2
- 241000228245 Aspergillus niger Species 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims description 2
- 108010093894 Xanthine oxidase Proteins 0.000 claims description 2
- 102100033220 Xanthine oxidase Human genes 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 150000003904 phospholipids Chemical class 0.000 claims description 2
- 108010001535 sulfhydryl oxidase Proteins 0.000 claims description 2
- 241000235648 Pichia Species 0.000 claims 2
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims 1
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 241000194108 Bacillus licheniformis Species 0.000 claims 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 1
- 241000588722 Escherichia Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000223218 Fusarium Species 0.000 claims 1
- 241000223198 Humicola Species 0.000 claims 1
- 241000235649 Kluyveromyces Species 0.000 claims 1
- 241001138401 Kluyveromyces lactis Species 0.000 claims 1
- 241000235395 Mucor Species 0.000 claims 1
- 241000228143 Penicillium Species 0.000 claims 1
- 102000003992 Peroxidases Human genes 0.000 claims 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- 241000235070 Saccharomyces Species 0.000 claims 1
- 241000187398 Streptomyces lividans Species 0.000 claims 1
- 241000223259 Trichoderma Species 0.000 claims 1
- 241000235013 Yarrowia Species 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 108040007629 peroxidase activity proteins Proteins 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 241000282887 Suidae Species 0.000 abstract description 10
- 239000003242 anti bacterial agent Substances 0.000 abstract description 9
- 229940088710 antibiotic agent Drugs 0.000 abstract description 9
- 241000251468 Actinopterygii Species 0.000 abstract description 8
- 244000309466 calf Species 0.000 abstract description 6
- 235000014590 basal diet Nutrition 0.000 description 32
- 102100033468 Lysozyme C Human genes 0.000 description 27
- 241000196324 Embryophyta Species 0.000 description 15
- 235000005911 diet Nutrition 0.000 description 12
- 230000037213 diet Effects 0.000 description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 241000277331 Salmonidae Species 0.000 description 7
- 235000019688 fish Nutrition 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 235000013594 poultry meat Nutrition 0.000 description 7
- 235000010469 Glycine max Nutrition 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 4
- 108010013639 Peptidoglycan Proteins 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 235000014103 egg white Nutrition 0.000 description 4
- 210000000969 egg white Anatomy 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 102100032487 Beta-mannosidase Human genes 0.000 description 3
- 235000019750 Crude protein Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 108010055059 beta-Mannosidase Proteins 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 239000007952 growth promoter Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004184 Avoparcin Substances 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 235000019738 Limestone Nutrition 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 239000006030 antibiotic growth promoter Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 235000019377 avoparcin Nutrition 0.000 description 2
- 108010053278 avoparcin Proteins 0.000 description 2
- JWFVWARSGMYXRN-HTQQBIQNSA-N avoparcin Chemical compound O([C@H]1[C@H](C(N[C@H](C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(N[C@H](C4=CC(O)=CC(O)=C4C=4C(O)=CC=C3C=4)C(O)=O)=O)CC3=C(O[C@@H]4O[C@@H](C)[C@H](O)[C@H](N)C4)C=C(C(=C3)Cl)OC=3C=C2C=C(C=3O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H]2O[C@@H](C)[C@H](O)[C@H](N)C2)OC2=CC=C1C=C2)C=1C=CC(O)=CC=1)=O)NC(=O)[C@@H](NC)C=1C=CC(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)=CC=1)[C@@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@H]1O JWFVWARSGMYXRN-HTQQBIQNSA-N 0.000 description 2
- 229950001335 avoparcin Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006028 limestone Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000004460 silage Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- YEBDWAHEIMUJQT-ZLCLUPBPSA-N (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O.CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YEBDWAHEIMUJQT-ZLCLUPBPSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 235000021411 American diet Nutrition 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- 241001227713 Chiron Species 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical class ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 208000003495 Coccidiosis Diseases 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 239000004181 Flavomycin Substances 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 1
- 206010023076 Isosporiasis Diseases 0.000 description 1
- 102100034866 Kallikrein-6 Human genes 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 102100038609 Lactoperoxidase Human genes 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102100037611 Lysophospholipase Human genes 0.000 description 1
- 102100026863 Lysozyme-like protein 4 Human genes 0.000 description 1
- 108050000796 Lysozyme-like protein 4 Proteins 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- 241000235388 Mucorales Species 0.000 description 1
- 102000003896 Myeloperoxidases Human genes 0.000 description 1
- 108090000235 Myeloperoxidases Proteins 0.000 description 1
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MNLRQHMNZILYPY-MDMHTWEWSA-N N-acetyl-alpha-D-muramic acid Chemical compound OC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(C)=O MNLRQHMNZILYPY-MDMHTWEWSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004188 Virginiamycin Substances 0.000 description 1
- 108010080702 Virginiamycin Proteins 0.000 description 1
- 235000019742 Vitamins premix Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000000007 bacterial human pathogen Species 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- PERZMHJGZKHNGU-JGYWJTCASA-N bambermycin Chemical compound O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@H](O1)C(=O)NC=1C(CCC=1O)=O)O)C)[C@H]1[C@@H](OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]1OC(N)=O PERZMHJGZKHNGU-JGYWJTCASA-N 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003224 coccidiostatic agent Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000019374 flavomycin Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- ZCZCOXLLICTZAH-UHFFFAOYSA-N hypothiocyanous acid Chemical compound OSC#N ZCZCOXLLICTZAH-UHFFFAOYSA-N 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 235000019462 natural additive Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 235000019553 satiation Nutrition 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000000891 standard diet Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000930 thermomechanical effect Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019373 virginiamycin Nutrition 0.000 description 1
- 229960003842 virginiamycin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- VJDOAZKNBQCAGE-VPENINKCSA-N xylitol 5-phosphate Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)COP(O)(O)=O VJDOAZKNBQCAGE-VPENINKCSA-N 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
- Y02A40/818—Alternative feeds for fish, e.g. in aquacultures
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The use of two antimicrobial enzymes for use in feed for monogastric or non-ruminant animals is disclosed to improve growth and feed conversion ratio of poultry, pigs, veal calves and fish. This may enable the farmer to avoid the use of growth promoting antibiotics. The enzymes have antibacterial activity and one can disrupt the cell wall of bacteria (eg. lysozyme) with another producing a compound toxic to bacteria (eg. oxidase). The efficacy of these enzymes is enhanced by the inclusion of a polyunsaturated fatty acid (PUFA) such as arachidonic acid.
Description
WO 00/21381 PCT/EP99/07835 _..
ANTIMICI~OBIAL ENZYMES IN ANIMAL FEED
Field of the invention This invention relates to the use of antimicrobial enzymes, such as oxidases and lysozyme, and a polyunsaturated fatty acid (PUFA), in (monogastric and non-ruminant) animal feed to improve growth and feed conversion ratio of pigs, poultry, fish and veal calves.
Background of the invention, Animals such as pigs, poultry, veal calves arid fish are grown intensively for the production of meat, fish and eggs. These animals are fed diets containing a variety of raw materials of animal and/or vegetable origin to supply energy and protein. Most of the feed that is consumed is produced commercially by the compound feed industry but a significant part is produced on the farm and fed directly. The feed is supplemented with vitamins and minerals to meet the requirements of animals for these essential nutrients.
In the case of poultry, the feed is also supplemented with coccidiostats to prevent coccidiosis. The use of industrially produced enzymes as feed additives has become almost common practice. Examples of such enzymes comprise phytases, alpha-amylases, proteases and various plant cell wall degrading enzymes such as f~-glucanases, endoxylanases and mannanases.
These enzymes are used to improve growth and feed conversion ratio and to reduce the environmental pollution caused by manure from pigs, poultry and fish.
However, feed costs are the most important cost factor in animal production.
During the 1950's it was realized that the addition of small amount of antibiotics to animal feed resulted in innproved zootechnical results in monogastric animals.
Nowadays, antibiotics are used routinely as feed additives. The mode of action of these antibiotics on the improvennent of growth and feed conversion ratio is still not fully understood. The generic term for this class of feed additives is growth promoters.
Examples of growth promoters include virginiamycin, tylosin, flavomycin and WO 00/21381 PCT/EP99/07835 _.
-7_ avoparcin.
The resistance of human pathogenic bacteria against antibiotics has been increasing rapidly. This has made it more difficult to cure people from bacterial infections. The widespread use of antibiotics in animal feed has been blamed by various experts to accelerate the build-up of resistance to various antibiotics. This has led to a ban on the use of all antibiotics as growth promoters in animal feed in Sweden and for specific antibiotics, such as avoparcin, in Denmark. It is likely that other countries will follow these examples due to pressure from consumer and health care organizations. The feed industry therefore is very much interested in natural additives with growth promoting effects without any therapeutical use in humans.
Certain enzymes are known to be active as antimicrobial agents, and these may be used in the preservation of food. Glucose oxidase has also been suggested for the preservation of silage fodder and silage grain (WO-A-98/01694, Suomen Sokeri Oy).
Plant cell wall degrading enzymes such as mannanase and b-glucanases are used as feed additives for diets containing high amounts of b-glucan and mannan to reduce the viscosity in the gastro-intestinal tract of monogastric animals caused by these non-starch polysaccharides. These enzymes also have some antifungal activity but do riot exhibit any antibacterial activity.
The antibacterial enzyme lysozyme has been added as a growth promoter to the feed in monogastric animals (Latvietis, J., et al, In: Vitamine Zusatzstoffe in der Ernaehrung von Mensch and Tier. Symposium 5th (1995). Editor Rainer Schubert et al.
Jena, September 28-29. ISBN 3.00.000361-4). These authors added lysozyme prepared from egg white to the feed ~of broilers and veal calves. Growth and feed conversion were allegedly improved. The concept however of using mixtures of antibacterial enzymes in combination with enzyme enhancers (eg. PUFAs) has not been published.
It is thus desirable for farmers and the compound feed industry to obtain an optimum growth and feed conversion ratio, at minimum cost, in a sustainable way, respecting demands from both consumer and health care organisations alike.
Description of the Invention The present invention provides an animal feed additive composition comprising a WO 00/21381 PCT/EP99/07835 _ .
mixture of antimicrobial enzymes which can show synergistic effects. The effect of the or each enzyme can be enhanced by the presence of one or more PUFAs. This may allow the improvement of growth and feed conversion ratio of animals such as pigs, poultry, veal calves and aquatic or marine animals such as fish, and can allow one to omit an antibiotic as growth promoter.
A first aspect of the present invention relates to an animal feed additive composition, suitable for a monogastric or non-ruminant animal, the composition comprising at least two antimicrobial enzymes and (as an enzyme enhancer) a polyunsaturated fatty acid {PUFA).
Preferably one or two of the enzymes are antibacterial enzymes. These enzymes may be of different types ancL~or may have different activity. One, eg. a first, enzyme may be able to disrupt the cell wall of bacteria. The enzyme may be one that can attack or degrade peptidoglycans. Far example, the enzyme may be able to cleave off peptidoglycans. A preferred enzyme for this task is lysozyme. This (first) enzyme may I5 be present at a concentration to give from 50,000 to 150,000, such as from 70,000 to 130,000, optimally from 90,C>00 to 110,000 Shugar units per kilogram (or unit) of animal feed. In terms of weight, therefore, this first enzyme may be present at an amount to give a concentration in the animal feed of from 1 to 8 grams per kg of feed, preferably from 2 to 7 grams per kg of seed and optimally from 3 to 5 grams per kg of feed.
The second enzyme rnay be able to generate a compound that is toxic to the bacteria. This may be the same bacteria, of different, from the bacteria whose cell walls can be disrupted or degraded) by the first enzyme. The compound is preferably a peroxide, eg. hydrogen peroxide. Thus preferred enzyme are oxidases.
Particularly preferred is glucose oxidase. This second enzyme may be present at a concentration to give from 500 to 1,500, preferably from 700 to 1,300, and optimally from 900 to 1,100 Sarett U per kilogram (or unit) of feed. Thus preferably this second enzyme may be present at an amount, by weight, to give a final concentration in the animal feed of from 1 to 8 grams per kg of feed, ~~referably from 2 to 7 grams per kg of feed, and optimally from 3 to 5 grams per kg of feed.
Enzymes can function as antimicrobial agents in the following ways:
a) disruption of the cell wall;
b) generation of a toxic compound;
c) removal of an essential nutrient; or d) inactivation oi: enzymes essential for growth.
Each of these will be discussed in turn.
a) Microbial cell walls vary in structure for fungi, yeasts, gram negative and gram positive bacteria. One c:an need different enzymes to disrupt the cell wall of these different types of microorganisms. The fungal and yeast cell wall, for example, may be disrupted by mannanases, chiainases and betaglucanases. The bacterial cell wall, however, is not sensitive to tlhese enzymes due to a different type of structure. Gram positive organisms have a peptidoglycan layer covered by some protein but essentially consists of peptidoglycan only. This substrate may be degraded by action of lysozyme (1,4-b-acetylmuramidase) which cleaves peptidoglycans between the C1 of N-acetyl-muramic acid and the C-4 of N-acetylglucosamine.
The peptidoglycan layer is covered by a tight lipopolysaccharide-protein-divalent cation-phospholipid layer in gram negative bacteria. This layer can hinder the efficacy of lysozyme in gram negative bacteria. Agents capable of disrupting this tight lipopolysaccharide layer stimulate the action of lysozyme by giving the enzyme access to the peptidoglycan layer.
b) Oxidases are capable of producing hydrogen peroxide which is lethal to most microorganisms. Glucose oxidase , for example, catalyses the conversion of glucose into gluconic acid and hydrogen peroxide. Xanthine oxidase, present in milk, is also capable of generating hydrogen peroxide.
Other antimicrobial compounds which may be enzymatically generated comprise hypothiocyanate (produced b:y lactoperoxidase), chloramines (produced by myeloperoxidase), free fatty acids (produced by lipase), poly-unsaturated fatty acids, lysophosphatidylcholine (produced by phospholipase A2) and xylitol-5-phosphate {produced. by xylitol phosphorylase). This list is by no means exhaustive, however.
c) Oxygen may be removed from the media by means of oxidases such as e.g.
glucose oxidase. Complete removal of oxygen prevents the growth of aerobic microorganisms.
d) Enzymes essential for growth of microorganisms may be inactivated by means of other enzymes. Sulfhydryl oxidases, for example, are capable of inactivating WO 00/21381 PCT/EP99/07835 _.
enzymes which depend on a<aive sulfhydryl groups for their activity.
The composition can comprise or enzyme enhancer, such as a compound that can significantly improve the activity of the or each antimicrobial (eg.
antibacterial) enzyme, preferably in a synergistic manner. The enzyme enhancer can comprise one or more polyunsaturated fatty acids, otherwise known as PUFAs. The or each PUFA can be of the n-3 or n-6 family. Preferably it is a C18, C20 or C22 PUFA. The PUFA can be provided in the form of a free fatty acid, as a fatty acid ester (e.g. methyl or ethyl ester), as a phospholipid and/or in t:he form of a triglyceride.
Preferred PUFAs incllude arachidonic acid (ARA), docosohexaenoic acid (DHA), eicosapentaenoic acid (EPA) and/or y-linoleic acid (GLA). Of these, ARA is preferred.
The PUFAs rnay be from a natural (e.g. vegetable or marine) source or may be derived from a single cell or :microbial source. In particular, the PUFA may be produced by a bacteria, fungus or yeast:. Fungi are preferred, preferably of the order Mucorales, for example Mortierella,1'~thium: or Entomophora. The preferred source of ARA is from Mortierella alpina or I'~thium: insidosum.
The PUFA may be present as an oil. Suitable oils that include ARA are available from DSM N.V., Wateringseweg 1, P.O. Box 1, 2600 MA Delft, The Netherlands, under the trade mark VEVODARz~. Another commercially available oil is ARASCO~ from Martek Corporation, 6480 bobbin Road, Columbia, MD 21045, United States of America. Other PUFAs are available, for example DHA as a DHA oil (DHASCO~
from Martek Corporation or DHA from Pronova, Norway, under the trade mark EPAX~).
The PUFA is preferably at a concentration that it allows it to be added to the animal feed to give a final concentration of from 0.1 or 1 to 1000, such as from 0.5 to 50 or 1 to 100, and preferably from 1 to 10 grams per kilogram (or unit) of feed.
All the antimicrobial enzymes can be produced on industrial scale and/or may be recombinant. Lysozyme is commercially available, isolated from egg white, or may be recombinant. The or each enzyme may be naturally occurring or may be an (eg.
recombinant) variant or mutant thereof.
The or each antibacterial enzyme is preferably recombinantly produced such as by expression of a heterologous gene or cDNA in a suitable organism, or alternatively by WO OO/Z1381 PCT/EP99/07835 _..
homologous (over)expression. of a suitable endogenous gene. The glucose oxidase gene, for example, has been overex~pressed in recombinant systems (WO-A- 89/12675, Chiron). ~:.ysozyme (from egg white) can be recombinantly expressed by expression of the gene in Aspergillus niger (Archer, D.B. et al., Bio/Technology 8:
741-745 (1990). Lysozyme mutants (produced by protein engineering) can also be used which have better heat stability and stronger antimicrobial action.
The antimicrobial enzymes used in the invention will usually be either ones which are not a natural constituent of the animal feed or are present in the feed at a concentration different from its natural concentrations.
A second aspect of the present invention relates to an animal feed composition comprising at least two antim.icrobial enzymes and a PUFA. As with the additive composition, a first enzyme may be able to disrupt the cell wall of bacteria, and a second enzyme may be capable of generating a compound toxic to the bacteria.
A third aspect of the invention relates to a process for the preparation of an animal feed composition, the process comprising adding to one or more edible feed substances) or ingredients) two or more antirnicrobial enzymes and a PUFA, or an additive of the first aspect.
The enzymes and/or F'UFA can be added to the animal feed composition separately from the feed substances) or ingredient(s), individually or in combination with other feed additives. Alternatively, or in addition, the or each enzyme can be an integral part of one of the feed substances. This aspect includes both preparing a feed composition with the two en~:ymes and PUFA or supplementing an existing feed composition with these compounds.
A particularly preferred method for the (exogenous) addition of the antimicrobial enzyme to animal feed is to add the or each enzyme as transgenic plant material and/or (e.g. transgenic) seed. The enzyme may thus have been synthesized through heterologous gene expression, for example t:he gene encoding the desired enzyme may be cloned in to a plant expression vector, under control of the appropriate plant expression signals, e.g. a tissue specific promoter, such as a seed specific promoter. The expression vector containing the gene encoding the enzyme can be subsequently transformed into plant cells, and transformed cells can be selected for regeneration into whole plants. The thus obtained transgenic plants can be grown and harvested, and those parts of the plants WO 00/21381 PCT/EP99/07835 _.
_7_ containing the heterologous (to the plant) enzyme can be included in one of the compositions, either as such ~or after further processing. Reference here is made to WO-A-91/14772 which discloses general methods for the (heterologous) expression of enzymes in (transgenic) plants, including methods for seed-specific expression of enzymes. The heterologous enzyme may be contained in the seed of the transgenic plants or it may be contained in other plant parts such as roots, stems, leaves, wood, flowers, bark and/or fruit.
The addition of the enzyme in the form of transgenic plant material, e.g.
transgenic seed containing the antimicrobial enzymes, may require the processing of the plant material so as to make the enzyme available, or at least improve its availability.
Such processing techniques may include various mechanical (eg. milling and/or grinding) techniques or thermomechanical treatments such as extrusion or expansion.
The antibacterial enz~rmes may be added to the feed composition at a concentration which varies a;s a function of diet composition, type of enzyme and target animal species.
Preferably the compositions of the invention do not contain any antibiotics.
The compositions) of the invention may also be free of a mineral component (such as zinc and/or iodine) and/or an im;munomodulating agent (such as ascorbic acid).
Although each of the two antimicrobial enzymes and the PUFA can all be produced by a micro-organism, it is preferred that the composition is free of microorganisms that produced any of these compounds (or microorganisms from Streptomyces). Furthermore, the composition may be devoid of microorganisms that produce lactic acid inside the animal (eg. those of the genus Lactobacillus or Enterococcus).
A fourth aspect of the present invention relates to a process for promoting growth and/or feed conversion in a monogastric or non-ruminant animal, the process comprising feeding the animal at least two antimicrobial enzymes and a PUFA or a feed composition of the first or second aspect or preparable by the third aspect.
Suitable animals include farm, monogastric and/or non-ruminant animals such as pigs (or piglets), poultry (suc:h as chickens, turkeys), calves or veal or aquatic (e.g. marine) animals (for example fish).
A fifth aspect relates t:o the use of a composition of the first aspect as an additive for a monogastric or non-ruminant animal feed composition.
_g_ Preferred features and characteristics of one aspect of the present invention are applicable to another aspect ~~reutatis mutandis.
The present invention will now be described by way of example with reference to the following Examples which are provided by way of illustration and are not intended to limit its scope.
Comparative Examples 1 to 4 and Example 5 Characterization of antibacterial enz me products Glucose oxidase (EC 1.1.3.4), an oxidase capable of generating hydrogen peroxide, was obtained as a commercial) product under the trade mark FERMIZYME GO~ from DSM/Royal Gist-brocades, Bakery Ingredients Division, PO Box 1, 2600 MA DELFT, The Netherlands. This enzyme preparation exhibits an activity of 500 Sarett Units per gram. One Sarett unit is the amount of enzyme that will cause an uptake of lOmm3 of oxygen per minute in a Warburg manometer at 30°C in the presence of excess oxygen and 3.3% glucose monohydrate in a phosphate buffer pH 5.9. The enzyme was produced by the fungus Aspergillus nige;r.
Lysozyme obtained from chicken egg-white was obtained as a commercial product under the trade mark DELVOZYME~ from DSM/Royal Gist-brocades, Dairy Ingredients Group, PO Box 1, 2600 MA DELFT, The Netherlands. The product contains 5.1 x 106 Shugar units/ml product. One Shugar unit is defined as the amount of enzyme which causes a decrease of absorbance of 0.001 per minute at 450 nm and pH 6.2 at 25°C in a suspension of Micrococcus lysodeikticus (0.25 mg/ml) obtainable from Sigma Chemicals.
Characterization of arachidonic acid Arachidonic acid (ARA) was also obtained from DSM/Royal Gist-brocades under the trade mark VEVODART"~. This is in the form of a microbial oil (ARA content at least 35%) obtained by culturing the fungus Mortierella alpina.
Application of antibacterial en.zymes in animal feed for poultry Trials we carried out with broilers to test the efficacy of glucose oxidase and lysozyme alone and the combination of both. Male broilers (Ross) we kept from day 1 WO 00/21381 PCT/EP99/07835 _.
to day 5 on a standard diet. .At day S, animals we selected from this group and are divided into cages. The weight of the animals and their variation were measured. The average weight and its deviation were equal per cage. Fifteen animals were kept in one cage. The cages were situated in an artificially heated, ventilated and illuminated broiler house. The floor space of each cage was 0.98 mz, with wire floors. The broiler house was illuminated for 24 hours per day. During the experimental period, light intensity was gradually reduced. The temperature was gradually reduced from 28°C
during the first week to 23°C during the last week of the experiment. Humidity in the broiler unit was approximately 60% during the experimental period. The animals had been vaccinated against New Castle disease (u:>ing the spray method) at an age of one and fourteen days.
The experiment lasted 33 days, comprising a pre-test period of 5 days and a test period of 28 days.
The experimental diets were offered ad lib. to the animals. Water was freely available. The feed was cold pelleted (temperatures were kept below 65°C) at a diameter of 3 millimeter.
The experiment comprised the following treatments:
1) basal diet (nega.tive control) 2) basal diet + glucose oxidase (1000 Sarett U/kg feed) 3) basal diet + lysozyme (100.000 Shugar units/kg of feed) 4) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100.000 Shugar units/kg of feed) 5) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed) + arachidonic acid (ARA) to a final concentration of 1 g/kg of feed.
Each treatment was replicated six times (90 birds per treatment in total).
Gain and feed conversion were measured. The composition of the feed (basal diets) used was:
Ingredients Content (%) Rye 10 Wheat 40 Soy oil 1 Animal fat 6 WO 00/Z1381 PCT/EP99/07835 _.
Manioc 4.3 Soya bean meal (45.4,~o crude protein) 22 Full fat toasted Soya beans 10 Meat meal tankage (58% crude protein) 3 Vitamins/premix 1 Limestone 0.9 Monocalciumphosphate 1.2 Salt (NaCI) 0.3 D,L-methionine 0.2 ME broilers {KCaI/kg;) 2850 Crude protein (%) 21.4 Crude fat (%) 10.5 Lysine (available, %) 1.23 (1.04) Methionine + cystein~e (available, %) 0.90 {0.79) The enzymes and arachidonic acid were added to this basal diet by mixing it first with a carrier.
The effects of the antibacterial enzymes and arachidonic acid on growth and feed conversion ratio in broilers between 5 and 33 days of age are shown below in Table 1.
Example Diet Feed Growth Feed Improvement Intake (g) conversionin feed (g) ratio conversion ratio 1 Basal diet 2,760 1,540 1.79 -2 Basal diet + 2,750 1,554 1.77 -0.02 glucose oxidase 3 Basal diet + 2,748 1,553 1.77 -0.02 lysozyme 4 Basal diet + 2,731 1,589 1.72 -0.05 glucose oxidase ~-lysozyme B
l di asa 2,710 1,595 I.70 -0.09 et +
oxidase +
lysozyme +
arachidonic acid The addition of one type of antibacterial enzyme or a combination of different types of antibacterial enzymes both improved the growth and feed conversion ratio in broilers. However, more importantly a synergistic effect was found for the combination S of glucose oxidase and lysozyme on the feed conversion ratio and the inclusion of arachidonic acid in diets contaiining antibacterial enzymes resulted in an even further improvement.
Comparative Examples 6 to 9 and Example 10 Application of antibacterial enzymes in animal feed for ~iQs Crossbred pigs (equal barrows and gifts; n =100) of a similar age and weight were used in this trial. They were housed in environmentally controlled rooms, and had ad lib. access to feed and water at all times. The room temperature was set initially at 29°C
and was lowered about 2°C peer week after the second week. The pigs were allotted to one of five treatments. There were two pigs in each pen with 10 replications (weight 1! 5 blocks) per treatment.
Body weight and pen feed consumption were measured weekly.
The basal diet was a typical American diet, of the composition:
Raw Material Content%r) Corn 63.6 Soyabean meal 30.9 Vitamin premix 0.25 Trace mineral premix 0.1 Selenium premix 0.05 Dicalcium phosphate 1.2 Salt (NaCI) 0.3 Limestone 3.6 No antibiotic was added to the feed.
PCT/EP99/07835 ..
The experiment comprised the following treatments (Examples 6 to 10):
a) basal diet (nel;ative control);
b) basal diet + glucose oxidase (1000 Sarett U/kg feed);
c) basal diet + lysozyme (100,000 Shugar units/kg of feed);
d) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shuga~r units/kg of feed);
e) basal diet + ghucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed) + arachidonic acid to a final concentration of 1 g/kg of feed.
The results obtained in terms of feed intake, growth and feed conversion ratio are shown below in Table 2.
Effects of antibacterial enzymes and ARA on growth and feed conversion ratio in growing pigs (23 to 54 kg body weight).
Exam Di le p et Daily Daily Feed Improvement Feed gain conversionin feed Intake (kg) ratio conversion ( ) ratio 6 Basal diet 2.20 0.90 2.44 -7 Basal diet + 2.15 0.90 2.39 -0.05 glucose oxidase 8 Basal diet + 2.14 0.89 2.40 -0.04 lysozyme 9 Basal diet + 2.10 0.94 2.23 -0.21 glucose oxidase +
lysozyme 10 Basal diet + 2.05 0.95 2.16 -0.28 oxidase +
lysozyme +
arachidonic acid The addition of one type of antibacterial enzyme or combinations of different types of antibacterial enzymes __<;howed a favourable effect on daily gain and feed WO 00/21381 PCT/EP99/07835 _..
conversion ratio. However, the combination of two different types of antibacterial enzymes (i.e. glucose oxidase and lysozyme) resulted in a surprising synergistic effect on feed conversion ratio and the addition of arachidonic acid to feed containing antibacteria enzymes resulted in a further improvement.
Comparative Examples 11 to '14 and Example 15 The use of antibacterial enz,~ie in fish nutrition Effects of supplemental antibacterial enzymes on growth and feed conversion ratio were studied with trout (Uncorhynchus mykiss).
The diet composition used was as follows:
a0 Raw material Content Soyabean meal 43 Soya beans, pressure cooked 20 Wheat gluten 20.5 Fish oil 12 1.5 L-lysine-HCl 0, g D, L-methionine 0,2 Vitamin/mineral premix 3.5 No growth promoting antibiotic was added to the feed.
Experiments were conducted with 200 trout with a mean initial body weight of 20 8.8 g/trout which were allottecL to 5 equal groups. Diets were fed to these 5 groups over a period of 53 days. The water temperature was kept constant at 15°C. The diets were fed twice daily to satiation avoiding feed losses. Weight gain and feed conversion ratio were determined.
The experiment comprised the following treatments (Examples 11 to 15):
a) basal diet (negatiive control);
b) basal diet + glucose oxidase (1000 Sarett U/kg feed);
c) basal diet + lyso:zyme (100,000 Shugar units/kg of feed);
d) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed); and WO 00/21381 PCT/EP99/07835 -.
e) basal diet + glucose oxidase (1000 Sarett LJ/kg of feed) + lysozyme {100,CC0 Shugar units/kg of feed) + arachidonic acid to a final concentration of 1 g/kg of feed.
The results obtained, in terms of growth and feed conversion, are shown below in Table 3.
Gain, feed intake and feed conversion ratio in trout fed for 53 days on diets supplemented with antibacterial enzymes + /- arachidonic acid.
Example Diet Feed Gain Feed Improvement Intake (g/trout)conversionin feed (g/trout) ratio conversion ratio 11 Basal diet 18.5 12.5 1.48 -12 Basal diet 20.6 14.1 1.46 -0.02 +
glucose oxidase 13 Basal diet 20.4 14.1 1.45 -0.03 +
lysozyme 14 Basal diet 21.5 16.4 1.31 -0.17 +
glucose oxidase +
lysozyme Basal diet 22.9 18.4 1.24 -0.24 +
oxidase +
lysozyme +
arachidonic acid 15 The results obtained demonstrate the favourable effects of one type of antibacterial enzyme or a combination of antibacterial enzymes on growth and feed conversion ratio in trout. The combination of different types of antibacterial enzymes showed a synergistic effect on feed conversion ratio and the addition of arachidonic acid to diets containing antibacterial enzymes gave a further improvement.
ANTIMICI~OBIAL ENZYMES IN ANIMAL FEED
Field of the invention This invention relates to the use of antimicrobial enzymes, such as oxidases and lysozyme, and a polyunsaturated fatty acid (PUFA), in (monogastric and non-ruminant) animal feed to improve growth and feed conversion ratio of pigs, poultry, fish and veal calves.
Background of the invention, Animals such as pigs, poultry, veal calves arid fish are grown intensively for the production of meat, fish and eggs. These animals are fed diets containing a variety of raw materials of animal and/or vegetable origin to supply energy and protein. Most of the feed that is consumed is produced commercially by the compound feed industry but a significant part is produced on the farm and fed directly. The feed is supplemented with vitamins and minerals to meet the requirements of animals for these essential nutrients.
In the case of poultry, the feed is also supplemented with coccidiostats to prevent coccidiosis. The use of industrially produced enzymes as feed additives has become almost common practice. Examples of such enzymes comprise phytases, alpha-amylases, proteases and various plant cell wall degrading enzymes such as f~-glucanases, endoxylanases and mannanases.
These enzymes are used to improve growth and feed conversion ratio and to reduce the environmental pollution caused by manure from pigs, poultry and fish.
However, feed costs are the most important cost factor in animal production.
During the 1950's it was realized that the addition of small amount of antibiotics to animal feed resulted in innproved zootechnical results in monogastric animals.
Nowadays, antibiotics are used routinely as feed additives. The mode of action of these antibiotics on the improvennent of growth and feed conversion ratio is still not fully understood. The generic term for this class of feed additives is growth promoters.
Examples of growth promoters include virginiamycin, tylosin, flavomycin and WO 00/21381 PCT/EP99/07835 _.
-7_ avoparcin.
The resistance of human pathogenic bacteria against antibiotics has been increasing rapidly. This has made it more difficult to cure people from bacterial infections. The widespread use of antibiotics in animal feed has been blamed by various experts to accelerate the build-up of resistance to various antibiotics. This has led to a ban on the use of all antibiotics as growth promoters in animal feed in Sweden and for specific antibiotics, such as avoparcin, in Denmark. It is likely that other countries will follow these examples due to pressure from consumer and health care organizations. The feed industry therefore is very much interested in natural additives with growth promoting effects without any therapeutical use in humans.
Certain enzymes are known to be active as antimicrobial agents, and these may be used in the preservation of food. Glucose oxidase has also been suggested for the preservation of silage fodder and silage grain (WO-A-98/01694, Suomen Sokeri Oy).
Plant cell wall degrading enzymes such as mannanase and b-glucanases are used as feed additives for diets containing high amounts of b-glucan and mannan to reduce the viscosity in the gastro-intestinal tract of monogastric animals caused by these non-starch polysaccharides. These enzymes also have some antifungal activity but do riot exhibit any antibacterial activity.
The antibacterial enzyme lysozyme has been added as a growth promoter to the feed in monogastric animals (Latvietis, J., et al, In: Vitamine Zusatzstoffe in der Ernaehrung von Mensch and Tier. Symposium 5th (1995). Editor Rainer Schubert et al.
Jena, September 28-29. ISBN 3.00.000361-4). These authors added lysozyme prepared from egg white to the feed ~of broilers and veal calves. Growth and feed conversion were allegedly improved. The concept however of using mixtures of antibacterial enzymes in combination with enzyme enhancers (eg. PUFAs) has not been published.
It is thus desirable for farmers and the compound feed industry to obtain an optimum growth and feed conversion ratio, at minimum cost, in a sustainable way, respecting demands from both consumer and health care organisations alike.
Description of the Invention The present invention provides an animal feed additive composition comprising a WO 00/21381 PCT/EP99/07835 _ .
mixture of antimicrobial enzymes which can show synergistic effects. The effect of the or each enzyme can be enhanced by the presence of one or more PUFAs. This may allow the improvement of growth and feed conversion ratio of animals such as pigs, poultry, veal calves and aquatic or marine animals such as fish, and can allow one to omit an antibiotic as growth promoter.
A first aspect of the present invention relates to an animal feed additive composition, suitable for a monogastric or non-ruminant animal, the composition comprising at least two antimicrobial enzymes and (as an enzyme enhancer) a polyunsaturated fatty acid {PUFA).
Preferably one or two of the enzymes are antibacterial enzymes. These enzymes may be of different types ancL~or may have different activity. One, eg. a first, enzyme may be able to disrupt the cell wall of bacteria. The enzyme may be one that can attack or degrade peptidoglycans. Far example, the enzyme may be able to cleave off peptidoglycans. A preferred enzyme for this task is lysozyme. This (first) enzyme may I5 be present at a concentration to give from 50,000 to 150,000, such as from 70,000 to 130,000, optimally from 90,C>00 to 110,000 Shugar units per kilogram (or unit) of animal feed. In terms of weight, therefore, this first enzyme may be present at an amount to give a concentration in the animal feed of from 1 to 8 grams per kg of feed, preferably from 2 to 7 grams per kg of seed and optimally from 3 to 5 grams per kg of feed.
The second enzyme rnay be able to generate a compound that is toxic to the bacteria. This may be the same bacteria, of different, from the bacteria whose cell walls can be disrupted or degraded) by the first enzyme. The compound is preferably a peroxide, eg. hydrogen peroxide. Thus preferred enzyme are oxidases.
Particularly preferred is glucose oxidase. This second enzyme may be present at a concentration to give from 500 to 1,500, preferably from 700 to 1,300, and optimally from 900 to 1,100 Sarett U per kilogram (or unit) of feed. Thus preferably this second enzyme may be present at an amount, by weight, to give a final concentration in the animal feed of from 1 to 8 grams per kg of feed, ~~referably from 2 to 7 grams per kg of feed, and optimally from 3 to 5 grams per kg of feed.
Enzymes can function as antimicrobial agents in the following ways:
a) disruption of the cell wall;
b) generation of a toxic compound;
c) removal of an essential nutrient; or d) inactivation oi: enzymes essential for growth.
Each of these will be discussed in turn.
a) Microbial cell walls vary in structure for fungi, yeasts, gram negative and gram positive bacteria. One c:an need different enzymes to disrupt the cell wall of these different types of microorganisms. The fungal and yeast cell wall, for example, may be disrupted by mannanases, chiainases and betaglucanases. The bacterial cell wall, however, is not sensitive to tlhese enzymes due to a different type of structure. Gram positive organisms have a peptidoglycan layer covered by some protein but essentially consists of peptidoglycan only. This substrate may be degraded by action of lysozyme (1,4-b-acetylmuramidase) which cleaves peptidoglycans between the C1 of N-acetyl-muramic acid and the C-4 of N-acetylglucosamine.
The peptidoglycan layer is covered by a tight lipopolysaccharide-protein-divalent cation-phospholipid layer in gram negative bacteria. This layer can hinder the efficacy of lysozyme in gram negative bacteria. Agents capable of disrupting this tight lipopolysaccharide layer stimulate the action of lysozyme by giving the enzyme access to the peptidoglycan layer.
b) Oxidases are capable of producing hydrogen peroxide which is lethal to most microorganisms. Glucose oxidase , for example, catalyses the conversion of glucose into gluconic acid and hydrogen peroxide. Xanthine oxidase, present in milk, is also capable of generating hydrogen peroxide.
Other antimicrobial compounds which may be enzymatically generated comprise hypothiocyanate (produced b:y lactoperoxidase), chloramines (produced by myeloperoxidase), free fatty acids (produced by lipase), poly-unsaturated fatty acids, lysophosphatidylcholine (produced by phospholipase A2) and xylitol-5-phosphate {produced. by xylitol phosphorylase). This list is by no means exhaustive, however.
c) Oxygen may be removed from the media by means of oxidases such as e.g.
glucose oxidase. Complete removal of oxygen prevents the growth of aerobic microorganisms.
d) Enzymes essential for growth of microorganisms may be inactivated by means of other enzymes. Sulfhydryl oxidases, for example, are capable of inactivating WO 00/21381 PCT/EP99/07835 _.
enzymes which depend on a<aive sulfhydryl groups for their activity.
The composition can comprise or enzyme enhancer, such as a compound that can significantly improve the activity of the or each antimicrobial (eg.
antibacterial) enzyme, preferably in a synergistic manner. The enzyme enhancer can comprise one or more polyunsaturated fatty acids, otherwise known as PUFAs. The or each PUFA can be of the n-3 or n-6 family. Preferably it is a C18, C20 or C22 PUFA. The PUFA can be provided in the form of a free fatty acid, as a fatty acid ester (e.g. methyl or ethyl ester), as a phospholipid and/or in t:he form of a triglyceride.
Preferred PUFAs incllude arachidonic acid (ARA), docosohexaenoic acid (DHA), eicosapentaenoic acid (EPA) and/or y-linoleic acid (GLA). Of these, ARA is preferred.
The PUFAs rnay be from a natural (e.g. vegetable or marine) source or may be derived from a single cell or :microbial source. In particular, the PUFA may be produced by a bacteria, fungus or yeast:. Fungi are preferred, preferably of the order Mucorales, for example Mortierella,1'~thium: or Entomophora. The preferred source of ARA is from Mortierella alpina or I'~thium: insidosum.
The PUFA may be present as an oil. Suitable oils that include ARA are available from DSM N.V., Wateringseweg 1, P.O. Box 1, 2600 MA Delft, The Netherlands, under the trade mark VEVODARz~. Another commercially available oil is ARASCO~ from Martek Corporation, 6480 bobbin Road, Columbia, MD 21045, United States of America. Other PUFAs are available, for example DHA as a DHA oil (DHASCO~
from Martek Corporation or DHA from Pronova, Norway, under the trade mark EPAX~).
The PUFA is preferably at a concentration that it allows it to be added to the animal feed to give a final concentration of from 0.1 or 1 to 1000, such as from 0.5 to 50 or 1 to 100, and preferably from 1 to 10 grams per kilogram (or unit) of feed.
All the antimicrobial enzymes can be produced on industrial scale and/or may be recombinant. Lysozyme is commercially available, isolated from egg white, or may be recombinant. The or each enzyme may be naturally occurring or may be an (eg.
recombinant) variant or mutant thereof.
The or each antibacterial enzyme is preferably recombinantly produced such as by expression of a heterologous gene or cDNA in a suitable organism, or alternatively by WO OO/Z1381 PCT/EP99/07835 _..
homologous (over)expression. of a suitable endogenous gene. The glucose oxidase gene, for example, has been overex~pressed in recombinant systems (WO-A- 89/12675, Chiron). ~:.ysozyme (from egg white) can be recombinantly expressed by expression of the gene in Aspergillus niger (Archer, D.B. et al., Bio/Technology 8:
741-745 (1990). Lysozyme mutants (produced by protein engineering) can also be used which have better heat stability and stronger antimicrobial action.
The antimicrobial enzymes used in the invention will usually be either ones which are not a natural constituent of the animal feed or are present in the feed at a concentration different from its natural concentrations.
A second aspect of the present invention relates to an animal feed composition comprising at least two antim.icrobial enzymes and a PUFA. As with the additive composition, a first enzyme may be able to disrupt the cell wall of bacteria, and a second enzyme may be capable of generating a compound toxic to the bacteria.
A third aspect of the invention relates to a process for the preparation of an animal feed composition, the process comprising adding to one or more edible feed substances) or ingredients) two or more antirnicrobial enzymes and a PUFA, or an additive of the first aspect.
The enzymes and/or F'UFA can be added to the animal feed composition separately from the feed substances) or ingredient(s), individually or in combination with other feed additives. Alternatively, or in addition, the or each enzyme can be an integral part of one of the feed substances. This aspect includes both preparing a feed composition with the two en~:ymes and PUFA or supplementing an existing feed composition with these compounds.
A particularly preferred method for the (exogenous) addition of the antimicrobial enzyme to animal feed is to add the or each enzyme as transgenic plant material and/or (e.g. transgenic) seed. The enzyme may thus have been synthesized through heterologous gene expression, for example t:he gene encoding the desired enzyme may be cloned in to a plant expression vector, under control of the appropriate plant expression signals, e.g. a tissue specific promoter, such as a seed specific promoter. The expression vector containing the gene encoding the enzyme can be subsequently transformed into plant cells, and transformed cells can be selected for regeneration into whole plants. The thus obtained transgenic plants can be grown and harvested, and those parts of the plants WO 00/21381 PCT/EP99/07835 _.
_7_ containing the heterologous (to the plant) enzyme can be included in one of the compositions, either as such ~or after further processing. Reference here is made to WO-A-91/14772 which discloses general methods for the (heterologous) expression of enzymes in (transgenic) plants, including methods for seed-specific expression of enzymes. The heterologous enzyme may be contained in the seed of the transgenic plants or it may be contained in other plant parts such as roots, stems, leaves, wood, flowers, bark and/or fruit.
The addition of the enzyme in the form of transgenic plant material, e.g.
transgenic seed containing the antimicrobial enzymes, may require the processing of the plant material so as to make the enzyme available, or at least improve its availability.
Such processing techniques may include various mechanical (eg. milling and/or grinding) techniques or thermomechanical treatments such as extrusion or expansion.
The antibacterial enz~rmes may be added to the feed composition at a concentration which varies a;s a function of diet composition, type of enzyme and target animal species.
Preferably the compositions of the invention do not contain any antibiotics.
The compositions) of the invention may also be free of a mineral component (such as zinc and/or iodine) and/or an im;munomodulating agent (such as ascorbic acid).
Although each of the two antimicrobial enzymes and the PUFA can all be produced by a micro-organism, it is preferred that the composition is free of microorganisms that produced any of these compounds (or microorganisms from Streptomyces). Furthermore, the composition may be devoid of microorganisms that produce lactic acid inside the animal (eg. those of the genus Lactobacillus or Enterococcus).
A fourth aspect of the present invention relates to a process for promoting growth and/or feed conversion in a monogastric or non-ruminant animal, the process comprising feeding the animal at least two antimicrobial enzymes and a PUFA or a feed composition of the first or second aspect or preparable by the third aspect.
Suitable animals include farm, monogastric and/or non-ruminant animals such as pigs (or piglets), poultry (suc:h as chickens, turkeys), calves or veal or aquatic (e.g. marine) animals (for example fish).
A fifth aspect relates t:o the use of a composition of the first aspect as an additive for a monogastric or non-ruminant animal feed composition.
_g_ Preferred features and characteristics of one aspect of the present invention are applicable to another aspect ~~reutatis mutandis.
The present invention will now be described by way of example with reference to the following Examples which are provided by way of illustration and are not intended to limit its scope.
Comparative Examples 1 to 4 and Example 5 Characterization of antibacterial enz me products Glucose oxidase (EC 1.1.3.4), an oxidase capable of generating hydrogen peroxide, was obtained as a commercial) product under the trade mark FERMIZYME GO~ from DSM/Royal Gist-brocades, Bakery Ingredients Division, PO Box 1, 2600 MA DELFT, The Netherlands. This enzyme preparation exhibits an activity of 500 Sarett Units per gram. One Sarett unit is the amount of enzyme that will cause an uptake of lOmm3 of oxygen per minute in a Warburg manometer at 30°C in the presence of excess oxygen and 3.3% glucose monohydrate in a phosphate buffer pH 5.9. The enzyme was produced by the fungus Aspergillus nige;r.
Lysozyme obtained from chicken egg-white was obtained as a commercial product under the trade mark DELVOZYME~ from DSM/Royal Gist-brocades, Dairy Ingredients Group, PO Box 1, 2600 MA DELFT, The Netherlands. The product contains 5.1 x 106 Shugar units/ml product. One Shugar unit is defined as the amount of enzyme which causes a decrease of absorbance of 0.001 per minute at 450 nm and pH 6.2 at 25°C in a suspension of Micrococcus lysodeikticus (0.25 mg/ml) obtainable from Sigma Chemicals.
Characterization of arachidonic acid Arachidonic acid (ARA) was also obtained from DSM/Royal Gist-brocades under the trade mark VEVODART"~. This is in the form of a microbial oil (ARA content at least 35%) obtained by culturing the fungus Mortierella alpina.
Application of antibacterial en.zymes in animal feed for poultry Trials we carried out with broilers to test the efficacy of glucose oxidase and lysozyme alone and the combination of both. Male broilers (Ross) we kept from day 1 WO 00/21381 PCT/EP99/07835 _.
to day 5 on a standard diet. .At day S, animals we selected from this group and are divided into cages. The weight of the animals and their variation were measured. The average weight and its deviation were equal per cage. Fifteen animals were kept in one cage. The cages were situated in an artificially heated, ventilated and illuminated broiler house. The floor space of each cage was 0.98 mz, with wire floors. The broiler house was illuminated for 24 hours per day. During the experimental period, light intensity was gradually reduced. The temperature was gradually reduced from 28°C
during the first week to 23°C during the last week of the experiment. Humidity in the broiler unit was approximately 60% during the experimental period. The animals had been vaccinated against New Castle disease (u:>ing the spray method) at an age of one and fourteen days.
The experiment lasted 33 days, comprising a pre-test period of 5 days and a test period of 28 days.
The experimental diets were offered ad lib. to the animals. Water was freely available. The feed was cold pelleted (temperatures were kept below 65°C) at a diameter of 3 millimeter.
The experiment comprised the following treatments:
1) basal diet (nega.tive control) 2) basal diet + glucose oxidase (1000 Sarett U/kg feed) 3) basal diet + lysozyme (100.000 Shugar units/kg of feed) 4) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100.000 Shugar units/kg of feed) 5) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed) + arachidonic acid (ARA) to a final concentration of 1 g/kg of feed.
Each treatment was replicated six times (90 birds per treatment in total).
Gain and feed conversion were measured. The composition of the feed (basal diets) used was:
Ingredients Content (%) Rye 10 Wheat 40 Soy oil 1 Animal fat 6 WO 00/Z1381 PCT/EP99/07835 _.
Manioc 4.3 Soya bean meal (45.4,~o crude protein) 22 Full fat toasted Soya beans 10 Meat meal tankage (58% crude protein) 3 Vitamins/premix 1 Limestone 0.9 Monocalciumphosphate 1.2 Salt (NaCI) 0.3 D,L-methionine 0.2 ME broilers {KCaI/kg;) 2850 Crude protein (%) 21.4 Crude fat (%) 10.5 Lysine (available, %) 1.23 (1.04) Methionine + cystein~e (available, %) 0.90 {0.79) The enzymes and arachidonic acid were added to this basal diet by mixing it first with a carrier.
The effects of the antibacterial enzymes and arachidonic acid on growth and feed conversion ratio in broilers between 5 and 33 days of age are shown below in Table 1.
Example Diet Feed Growth Feed Improvement Intake (g) conversionin feed (g) ratio conversion ratio 1 Basal diet 2,760 1,540 1.79 -2 Basal diet + 2,750 1,554 1.77 -0.02 glucose oxidase 3 Basal diet + 2,748 1,553 1.77 -0.02 lysozyme 4 Basal diet + 2,731 1,589 1.72 -0.05 glucose oxidase ~-lysozyme B
l di asa 2,710 1,595 I.70 -0.09 et +
oxidase +
lysozyme +
arachidonic acid The addition of one type of antibacterial enzyme or a combination of different types of antibacterial enzymes both improved the growth and feed conversion ratio in broilers. However, more importantly a synergistic effect was found for the combination S of glucose oxidase and lysozyme on the feed conversion ratio and the inclusion of arachidonic acid in diets contaiining antibacterial enzymes resulted in an even further improvement.
Comparative Examples 6 to 9 and Example 10 Application of antibacterial enzymes in animal feed for ~iQs Crossbred pigs (equal barrows and gifts; n =100) of a similar age and weight were used in this trial. They were housed in environmentally controlled rooms, and had ad lib. access to feed and water at all times. The room temperature was set initially at 29°C
and was lowered about 2°C peer week after the second week. The pigs were allotted to one of five treatments. There were two pigs in each pen with 10 replications (weight 1! 5 blocks) per treatment.
Body weight and pen feed consumption were measured weekly.
The basal diet was a typical American diet, of the composition:
Raw Material Content%r) Corn 63.6 Soyabean meal 30.9 Vitamin premix 0.25 Trace mineral premix 0.1 Selenium premix 0.05 Dicalcium phosphate 1.2 Salt (NaCI) 0.3 Limestone 3.6 No antibiotic was added to the feed.
PCT/EP99/07835 ..
The experiment comprised the following treatments (Examples 6 to 10):
a) basal diet (nel;ative control);
b) basal diet + glucose oxidase (1000 Sarett U/kg feed);
c) basal diet + lysozyme (100,000 Shugar units/kg of feed);
d) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shuga~r units/kg of feed);
e) basal diet + ghucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed) + arachidonic acid to a final concentration of 1 g/kg of feed.
The results obtained in terms of feed intake, growth and feed conversion ratio are shown below in Table 2.
Effects of antibacterial enzymes and ARA on growth and feed conversion ratio in growing pigs (23 to 54 kg body weight).
Exam Di le p et Daily Daily Feed Improvement Feed gain conversionin feed Intake (kg) ratio conversion ( ) ratio 6 Basal diet 2.20 0.90 2.44 -7 Basal diet + 2.15 0.90 2.39 -0.05 glucose oxidase 8 Basal diet + 2.14 0.89 2.40 -0.04 lysozyme 9 Basal diet + 2.10 0.94 2.23 -0.21 glucose oxidase +
lysozyme 10 Basal diet + 2.05 0.95 2.16 -0.28 oxidase +
lysozyme +
arachidonic acid The addition of one type of antibacterial enzyme or combinations of different types of antibacterial enzymes __<;howed a favourable effect on daily gain and feed WO 00/21381 PCT/EP99/07835 _..
conversion ratio. However, the combination of two different types of antibacterial enzymes (i.e. glucose oxidase and lysozyme) resulted in a surprising synergistic effect on feed conversion ratio and the addition of arachidonic acid to feed containing antibacteria enzymes resulted in a further improvement.
Comparative Examples 11 to '14 and Example 15 The use of antibacterial enz,~ie in fish nutrition Effects of supplemental antibacterial enzymes on growth and feed conversion ratio were studied with trout (Uncorhynchus mykiss).
The diet composition used was as follows:
a0 Raw material Content Soyabean meal 43 Soya beans, pressure cooked 20 Wheat gluten 20.5 Fish oil 12 1.5 L-lysine-HCl 0, g D, L-methionine 0,2 Vitamin/mineral premix 3.5 No growth promoting antibiotic was added to the feed.
Experiments were conducted with 200 trout with a mean initial body weight of 20 8.8 g/trout which were allottecL to 5 equal groups. Diets were fed to these 5 groups over a period of 53 days. The water temperature was kept constant at 15°C. The diets were fed twice daily to satiation avoiding feed losses. Weight gain and feed conversion ratio were determined.
The experiment comprised the following treatments (Examples 11 to 15):
a) basal diet (negatiive control);
b) basal diet + glucose oxidase (1000 Sarett U/kg feed);
c) basal diet + lyso:zyme (100,000 Shugar units/kg of feed);
d) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed); and WO 00/21381 PCT/EP99/07835 -.
e) basal diet + glucose oxidase (1000 Sarett LJ/kg of feed) + lysozyme {100,CC0 Shugar units/kg of feed) + arachidonic acid to a final concentration of 1 g/kg of feed.
The results obtained, in terms of growth and feed conversion, are shown below in Table 3.
Gain, feed intake and feed conversion ratio in trout fed for 53 days on diets supplemented with antibacterial enzymes + /- arachidonic acid.
Example Diet Feed Gain Feed Improvement Intake (g/trout)conversionin feed (g/trout) ratio conversion ratio 11 Basal diet 18.5 12.5 1.48 -12 Basal diet 20.6 14.1 1.46 -0.02 +
glucose oxidase 13 Basal diet 20.4 14.1 1.45 -0.03 +
lysozyme 14 Basal diet 21.5 16.4 1.31 -0.17 +
glucose oxidase +
lysozyme Basal diet 22.9 18.4 1.24 -0.24 +
oxidase +
lysozyme +
arachidonic acid 15 The results obtained demonstrate the favourable effects of one type of antibacterial enzyme or a combination of antibacterial enzymes on growth and feed conversion ratio in trout. The combination of different types of antibacterial enzymes showed a synergistic effect on feed conversion ratio and the addition of arachidonic acid to diets containing antibacterial enzymes gave a further improvement.
Claims (23)
1. An animal feed additive composition comprising at least two antimicrobial enzymes and a polyunsaturated fatty acid (PUFA).
2. An animal feed composition comprising at least two antimicrobial enzymes and a polyunsaturated. fatty acid (PUFA).
3. A composition according to claim 1 or 2 wherein the or each antimicrobial enzyme is an antibacterial enzyme.
4. A composition according to claim 3 wherein one or more of the antibacterial enzymes comprises glucose oxidase, sulphydryl oxidase, xanthine oxidase, peroxidase or a lysozyme.
5. A composition according to claims 1 or 2 wherein one of the enzymes is able to disrupt the cell wall of bacteria and/or another enzyme is capable of generating a compound that is toxic to the bacteria.
6. A composition according to any preceding claim wherein the enzymes are a lysozyme and an oxidase.
7. A composition according to any preceding claim wherein the PUFA
comprises an n-3 or n-6 C18, C20 or C22 PUFA.
comprises an n-3 or n-6 C18, C20 or C22 PUFA.
8. A composition according to any preceding claim wherein the PUFA is in the form of a free fatty acid, fatty acid ester, phospholipid or triglyceride.
9. A composition according to any preceding claim wherein the PUFA
comprises arachidonic acid (ARA).
comprises arachidonic acid (ARA).
10. A composition according to any preceding claim wherein the or each antibacterial enzyme is derived from an animal, an animal product, a plant or a microorganism.
11. A composition according to any preceding claim wherein the or each antibacterial enzyme is of microbial origin and/or is a recombinant protein.
12. A composition according to any preceding claim wherein the or each enzyme is derived from, produced by or present in a microorganism such as a bacteria, yeast or (filamentous) fungus.
13. A composition according to claim 11 wherein the microorganism is of the genus Streptomyces, Bacillus, Escherichia, Saccharomyces, Kluyveromyces, Hansenula, Pichia, Yarrowia, Candida, Aspergillus, Trichoderma, Penicillium, Mucor, Fusarium or Humicola.
14. A composition .according to claim 13 wherein the microorganism is Streptomyces lividans, Escherichia coli, Bacillus licheniformis, Kluyveromyces lactis Aspergillus niger, or Mortierella alpina.
15. A composition according to any preceding claim wherein the enzyme is contained in plant material, optionally obtained from a transgenic plant.
16. A composition according to claim 15 wherein the antibacterial enzymes glucose oxidase and/or lysozyme are contained in seeds of a transgenic plant.
17. A composition according to any preceding claim which is adapted to comprise from 10 to 10,000 Sarett Units of glucose oxidase per kg feed and 1000 to 1,000,000 Shugar units of lysozyme per kg feed.
18. A composition according to any preceding claim which comprises 1-1000 g of arachidonic acid per kg of feed.
19. A process for the production of a feed composition for a monogastric or non-ruminant animal, the process comprising adding two antimicrobial enzymes and a PUFA to, or mixing a feed additive composition according to any of claims 1 or 3 to 18 with, one or more edible feed substance(s) or ingredient(s).
20. An animal feed composition comprising an additive composition according to any of claims 1 or 3 to 18 and one or more edible feed substance(s) or ingredient(s).
21. A process for promoting growth and/or feed conversion in a monogastric or non-ruminant animal, the process comprising feeding the animal at least two antimicrobial enzymes and a PUFA or a composition as defined in any of claims 1 to 18 or 20.
22. A process according to claim 21 wherein the animal is a pig, poultry (chicken, turkey), veal or aquatic animal.
23. The use of a composition according to any of claims 1, 3 to 18 as an additive for a monogastric animal feed composition.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98308456 | 1998-10-15 | ||
EP98308456.7 | 1998-10-15 | ||
PCT/EP1999/007835 WO2000021381A1 (en) | 1998-10-15 | 1999-10-15 | Antimicrobial enzymes in animal feed |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2346075A1 true CA2346075A1 (en) | 2000-04-20 |
Family
ID=8235112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002346075A Abandoned CA2346075A1 (en) | 1998-10-15 | 1999-10-15 | Antimicrobial enzymes in animal feed |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1121021A1 (en) |
JP (1) | JP2002527046A (en) |
KR (1) | KR20010089301A (en) |
CN (1) | CN1323166A (en) |
AU (1) | AU753232B2 (en) |
BR (1) | BR9914555A (en) |
CA (1) | CA2346075A1 (en) |
CZ (1) | CZ20011328A3 (en) |
GB (1) | GB2349794B (en) |
HK (1) | HK1030855A1 (en) |
HU (1) | HUP0104001A2 (en) |
ID (1) | ID28812A (en) |
IL (1) | IL142384A0 (en) |
NL (1) | NL1013308C2 (en) |
NO (1) | NO20011833L (en) |
NZ (1) | NZ510932A (en) |
PL (1) | PL347250A1 (en) |
SK (1) | SK5022001A3 (en) |
TR (1) | TR200101074T2 (en) |
WO (1) | WO2000021381A1 (en) |
ZA (1) | ZA200102825B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200187525A1 (en) * | 2017-05-09 | 2020-06-18 | Grassa B.V. | Method and system for the production of non-ruminant animal feed |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA78486C2 (en) | 1999-12-10 | 2007-04-10 | Хемджен Корпорейшн | Formulation for oral use in fowls and animals for treating or decreasing risk of infections of digestive tract (variants), use of composition (variants), method for treating or decreasing risk of infections of digestive tract (variants) |
AU2002250126A1 (en) * | 2001-02-14 | 2002-08-28 | Ventria Bioscience | Feed additive compositions and methods |
WO2003009702A1 (en) * | 2001-07-20 | 2003-02-06 | Dsm Ip Assets B.V. | Animal feed with antimicrobial reactive oxygen species |
US20040180126A1 (en) * | 2001-07-20 | 2004-09-16 | Arie Karst Kies | Animal feed with low pufa concentration |
GB2379166A (en) * | 2002-10-22 | 2003-03-05 | Dsm Nv | Animal feed |
GB2379165A (en) * | 2002-10-22 | 2003-03-05 | Dsm Nv | Animal feed |
AU2003900927A0 (en) * | 2003-02-28 | 2003-03-13 | Biodiem Ltd | Growth promotion method |
EP1527700A1 (en) * | 2003-10-29 | 2005-05-04 | Cerestar Holding B.V. | Fish feed and process for preparing the same |
GB0413954D0 (en) | 2004-06-22 | 2004-07-28 | Altunkaya Ali | Compositions for topical treatment |
KR100857771B1 (en) * | 2006-10-26 | 2008-09-09 | 주식회사 바이넥스 | Compositions for addition to feed for fish comprising Bacillus polyfermenticus, Bacillus licheniformis and Saccharomyces serevisiae |
KR100886623B1 (en) * | 2008-07-01 | 2009-03-05 | 보원코리아(주) | Method for feed hens a breeding |
US8865637B2 (en) | 2010-02-25 | 2014-10-21 | Novozymes Als | Variants of a lysozyme and polynucleotides encoding same |
WO2012035103A1 (en) | 2010-09-16 | 2012-03-22 | Novozymes A/S | Lysozymes |
BR112014012170A2 (en) | 2011-11-25 | 2020-06-23 | Novozymes A/S | isolated polypetide, composition, animal feed additive, use of a polypetide, methods of isolating rodent DNA, and producing a polypeptide, isolated polynucleotide, nucleic acid construct or expression vector, recombinant host cell, and plant, plant part or plant cell |
JP6215231B2 (en) | 2012-01-23 | 2017-10-18 | モルフォシス・アーゲー | Use as tag for lysozyme |
CN102726614B (en) * | 2012-07-04 | 2014-01-22 | 山东祥维斯生物科技有限公司 | Feed animal intestinal tract protective agent, preparation method and application thereof |
CN105120681A (en) * | 2013-05-08 | 2015-12-02 | 诺维信公司 | Animal feed enzymes |
CN103518961B (en) * | 2013-09-27 | 2016-03-30 | 河南牧翔动物药业有限公司 | A kind of additive agent for chicken feed and application thereof |
AU2016288515B2 (en) | 2015-07-02 | 2020-09-10 | Dsm Ip Assets B.V. | Methods of improving animal performance |
EP3970506A1 (en) * | 2015-07-02 | 2022-03-23 | Novozymes A/S | Animal feed compositions comprising gh25 lysozyme and ec 3.1.3.26 phytase and uses thereof |
WO2017140807A1 (en) | 2016-02-16 | 2017-08-24 | Monaghan Mushrooms Group | Fungal polypeptides having lysozyme activity |
BR112019013574A2 (en) | 2017-01-04 | 2020-06-23 | Novozymes A/S | MICROBIAL LYSOZYME OR A COMPOSITION, METHOD OF PREVENTION, RELIEF OR TREATMENT OF IRRITABLE GUT SYNDROME OR INFLAMMATORY INTESTINAL DISEASE, AND METHOD OF IMPROVING INTESTINAL HEALTH IN HUMAN BEINGS. |
BR112019023329A2 (en) | 2017-05-12 | 2020-06-16 | Novozymes A/S | COMPOSITION, GRANULE, ANIMAL FEED ADDITIVE, ANIMAL FEED, LIQUID FORMULATION, METHODS FOR IMPROVING ONE OR MORE ANIMAL PERFORMANCE PARAMETERS, TO PREPARE ANIMAL FEED AND TO PRODUCE THE POLYPEPTIDE, USE OF THE COMPOSITION, POLYPOINT NUCLEIC ACID EXPRESSION VECTOR, E, RECOMBINANT HOST CELL |
AR112955A1 (en) | 2017-09-01 | 2020-01-08 | Novozymes As | ANIMAL FEED ADDITIVES INCLUDING POLYPEPTIDES HAVING PROTEASE ACTIVITY AND USES OF THE SAME |
EP3675646A1 (en) | 2017-09-01 | 2020-07-08 | Novozymes A/S | Animal feed additives comprising polypeptide having protease activity and uses thereof |
WO2019121938A1 (en) * | 2017-12-20 | 2019-06-27 | Dsm Ip Assets B.V. | Animal feed compositions comprising muramidase and uses thereof |
BR112020018166A2 (en) | 2018-03-05 | 2021-02-02 | Novozymes A/S | ruminant feed composition comprising a muramidase |
CN108991229A (en) * | 2018-07-05 | 2018-12-14 | 李新旗 | A kind of complex microorganism nutrition enzyme element |
WO2020043836A1 (en) | 2018-08-31 | 2020-03-05 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
AU2019339736A1 (en) | 2018-09-11 | 2021-03-04 | Dsm Ip Assets B.V. | Animal feed composition and use thereof |
AU2019339615A1 (en) | 2018-09-11 | 2021-03-04 | Dsm Ip Assets B.V. | Animal feed composition comprising muramidase and use thereof |
WO2020053276A1 (en) | 2018-09-11 | 2020-03-19 | Dsm Ip Assets B.V. | Animal feed composition and use thereof |
CA3109447A1 (en) | 2018-09-11 | 2020-03-19 | Dsm Ip Assets B.V. | Animal feed composition and use thereof |
US20220046954A1 (en) | 2018-09-11 | 2022-02-17 | Dsm Ip Assets B.V. | Animal feed composition and use thereof |
CA3108945A1 (en) | 2018-09-17 | 2020-03-26 | Dsm Ip Assets B.V. | Animal feed composition and use thereof |
US20220202044A1 (en) | 2019-03-11 | 2022-06-30 | Novozymes A/S | Fibrous maize-based animal feed with gh30 glucuronoxylan hydrolase |
KR102258855B1 (en) * | 2019-08-27 | 2021-05-28 | 이종산 | Sealing agent of body hole to prevent of leaking out excreta from dead person and method for sealing the same |
EP4307915A1 (en) | 2021-03-16 | 2024-01-24 | DSM IP Assets B.V. | Animal feed composition and use thereof |
CN115039838A (en) * | 2022-06-04 | 2022-09-13 | 宁夏夏盛实业集团有限公司 | Combination and application of feeding complex enzyme containing microbial fermentation lysozyme and penicillium-derived glucose oxidase |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0366869A3 (en) * | 1988-10-17 | 1991-06-12 | Lycon Ag | Bacteriostatic, bactericidal and antifungal composition and methods of use thereof |
DE3841152A1 (en) * | 1988-12-07 | 1990-06-13 | Hoechst Ag | USE OF BACTERIA-LYING ENZYME PRODUCT AS AN ADDITIVE TO IMPROVE THE FEED RECYCLING IN ANIMAL PRODUCTION |
GB9200891D0 (en) * | 1992-01-16 | 1992-03-11 | Mann Stephen P | Formulation of microorganisms |
AT506U1 (en) * | 1994-11-22 | 1995-12-27 | Erber Erich Kg | FEEDING MATERIALS DRINKING WATER ADDED TO IMPROVE THE STRESS RESISTANCE AND IMMUNITY OF FARM ANIMALS |
SE510498C2 (en) * | 1996-02-14 | 1999-05-31 | Biofeed Thailand Co Ltd | Animal feed additive containing microorganisms |
-
1999
- 1999-10-15 CA CA002346075A patent/CA2346075A1/en not_active Abandoned
- 1999-10-15 CN CN99812124A patent/CN1323166A/en active Pending
- 1999-10-15 ID IDW20010826A patent/ID28812A/en unknown
- 1999-10-15 PL PL99347250A patent/PL347250A1/en not_active Application Discontinuation
- 1999-10-15 IL IL14238499A patent/IL142384A0/en unknown
- 1999-10-15 NZ NZ510932A patent/NZ510932A/en unknown
- 1999-10-15 TR TR2001/01074T patent/TR200101074T2/en unknown
- 1999-10-15 GB GB0014421A patent/GB2349794B/en not_active Expired - Fee Related
- 1999-10-15 EP EP99952589A patent/EP1121021A1/en not_active Withdrawn
- 1999-10-15 JP JP2000575375A patent/JP2002527046A/en active Pending
- 1999-10-15 SK SK502-2001A patent/SK5022001A3/en unknown
- 1999-10-15 AU AU64730/99A patent/AU753232B2/en not_active Ceased
- 1999-10-15 CZ CZ20011328A patent/CZ20011328A3/en unknown
- 1999-10-15 HU HU0104001A patent/HUP0104001A2/en unknown
- 1999-10-15 BR BR9914555-3A patent/BR9914555A/en not_active Application Discontinuation
- 1999-10-15 NL NL1013308A patent/NL1013308C2/en not_active IP Right Cessation
- 1999-10-15 WO PCT/EP1999/007835 patent/WO2000021381A1/en not_active Application Discontinuation
- 1999-10-15 KR KR1020017004695A patent/KR20010089301A/en not_active Application Discontinuation
-
2001
- 2001-03-03 HK HK01101563A patent/HK1030855A1/en not_active IP Right Cessation
- 2001-04-05 ZA ZA200102825A patent/ZA200102825B/en unknown
- 2001-04-10 NO NO20011833A patent/NO20011833L/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200187525A1 (en) * | 2017-05-09 | 2020-06-18 | Grassa B.V. | Method and system for the production of non-ruminant animal feed |
Also Published As
Publication number | Publication date |
---|---|
NL1013308C2 (en) | 2000-06-30 |
GB0014421D0 (en) | 2000-08-09 |
ZA200102825B (en) | 2001-10-08 |
BR9914555A (en) | 2001-06-26 |
HK1030855A1 (en) | 2001-05-25 |
AU6473099A (en) | 2000-05-01 |
NL1013308A1 (en) | 2000-04-25 |
JP2002527046A (en) | 2002-08-27 |
PL347250A1 (en) | 2002-03-25 |
HUP0104001A2 (en) | 2002-02-28 |
CN1323166A (en) | 2001-11-21 |
CZ20011328A3 (en) | 2001-08-15 |
NO20011833D0 (en) | 2001-04-10 |
SK5022001A3 (en) | 2001-09-11 |
NZ510932A (en) | 2002-10-25 |
NO20011833L (en) | 2001-06-11 |
ID28812A (en) | 2001-07-05 |
GB2349794A (en) | 2000-11-15 |
GB2349794B (en) | 2001-08-22 |
TR200101074T2 (en) | 2001-09-21 |
EP1121021A1 (en) | 2001-08-08 |
KR20010089301A (en) | 2001-09-29 |
IL142384A0 (en) | 2002-03-10 |
WO2000021381A1 (en) | 2000-04-20 |
AU753232B2 (en) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU753232B2 (en) | Antimicrobial enzymes in animal feed | |
US20040180126A1 (en) | Animal feed with low pufa concentration | |
CA2465202C (en) | Phytase-containing animal food and method | |
RU2275052C2 (en) | Phytase-containing aqueous liquid, method for production thereof, phytase-containing granulated material and method for production thereof, animal feed, premix or semi-finished animal feed, method for production thereof, and animal growth stimulation | |
US6017530A (en) | Phospholipases in animal feed | |
GB2379166A (en) | Animal feed | |
GB2379165A (en) | Animal feed | |
US6162473A (en) | Hemicellulase use in feeds with low caloric content | |
CN112689461A (en) | Animal feed composition and use thereof | |
Dierick et al. | Endogenous lipolysis in feedstuffs and compound feeds for pigs: effects of storage time and conditions and lipase and/or emulsifier addition | |
JPH08242777A (en) | Application of krill enzyme in feed for aquatic animal, and feed for aquatic animal containing krill enzyme | |
MXPA01003780A (en) | Antimicrobial enzymes in animal feed | |
Golovanova et al. | Effect of Kurunga Probiotic on Growth Parameters, the Activity of Intestinal Glycosidases and Peptidases, and Excreta Quality in Quail Conditions | |
KR20010050310A (en) | Microorganism composition containing Rhodopseudomonas sp. and use thereof | |
Sjofjan et al. | The influence used of calcium and acidifier to performance, internal egg quality, and metabolizable energy of laying hens: In-vivo trial | |
WO2023117463A1 (en) | A method for reducing ammonia emission of animals | |
EP4297583A1 (en) | Method of improving carbohydrate digestibility by a carbohydratase in an animal feed by employing serine protease | |
WO2022179757A1 (en) | Method of improving carbohydrate digestibility by a carbohydratase in an animal feed by employing serine protease | |
WO2022194728A1 (en) | Animal feed composition and use thereof | |
KR100338193B1 (en) | New kind of protista schizochytrium sp. Sπ-2(KCTC 0694BP) and a method of cultivation | |
Alimon | AGRICULTURAL BY-PRODUCTS AND POULTRY NUTRITION IN MALAYSIA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20031015 |